Chun-Seok Cho1, Hwan-Woo Park1,2, Allison Ho1, Ian A Semple1, Boyoung Kim1, Insook Jang1, Haeli Park1, Shannon Reilly1,3,4, Alan R Saltiel1,3,4, Jun Hee Lee1. 1. Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI. 2. Department of Cell Biology, Myunggok Medical Research Institute, Konyang University College of Medicine, Daejeon, Republic of Korea. 3. Life Sciences Institute, University of Michigan, Ann Arbor, MI. 4. Institute for Diabetes and Metabolic Health, Departments of Medicine and Pharmacology, University of California, San Diego, La Jolla, CA.
Abstract
Obesity commonly leads to hepatic steatosis, which often provokes lipotoxic injuries to hepatocytes that cause nonalcoholic steatohepatitis (NASH). NASH, in turn, is associated with the accumulation of insoluble protein aggregates that are composed of ubiquitinated proteins and ubiquitin adaptor p62/sequestosome 1 (SQSTM1). Formation of p62 inclusions in hepatocytes is the critical marker that distinguishes simple fatty liver from NASH and predicts a poor prognostic outcome for subsequent liver carcinogenesis. However, the molecular mechanism by which lipotoxicity induces protein aggregation is currently unknown. Here, we show that, upon saturated fatty acid-induced lipotoxicity, TANK binding kinase 1 (TBK1) is activated and phosphorylates p62. TBK1-mediated p62 phosphorylation is important for lipotoxicity-induced aggregation of ubiquitinated proteins and formation of large protein inclusions in hepatocytes. In addition, cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING), upstream regulators of TBK1, are involved in lipotoxic activation of TBK1 and subsequent p62 phosphorylation in hepatocytes. Furthermore, TBK1 inhibition prevented formation of ubiquitin-p62 aggregates not only in cultured hepatocytes, but also in mouse models of obesity and NASH. CONCLUSION: These results suggest that lipotoxic activation of TBK1 and subsequent p62 phosphorylation are critical steps in the NASH pathology of protein inclusion accumulation in hepatocytes. This mechanism can provide an explanation for how hypernutrition and obesity promote the development of severe liver pathologies, such as steatohepatitis and liver cancer, by facilitating the formation of p62 inclusions. (Hepatology 2018).
Obesity commonly leads to hepatic steatosis, which often provokes lipotoxic injuries to hepatocytes that cause nonalcoholic steatohepatitis (NASH). NASH, in turn, is associated with the accumulation of insoluble protein aggregates that are composed of ubiquitinated proteins and ubiquitin adaptor p62/sequestosome 1 (SQSTM1). Formation of p62 inclusions in hepatocytes is the critical marker that distinguishes simple fatty liver from NASH and predicts a poor prognostic outcome for subsequent liver carcinogenesis. However, the molecular mechanism by which lipotoxicity induces protein aggregation is currently unknown. Here, we show that, upon saturated fatty acid-induced lipotoxicity, TANK binding kinase 1 (TBK1) is activated and phosphorylates p62. TBK1-mediated p62 phosphorylation is important for lipotoxicity-induced aggregation of ubiquitinated proteins and formation of large protein inclusions in hepatocytes. In addition, cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING), upstream regulators of TBK1, are involved in lipotoxic activation of TBK1 and subsequent p62 phosphorylation in hepatocytes. Furthermore, TBK1 inhibition prevented formation of ubiquitin-p62 aggregates not only in cultured hepatocytes, but also in mouse models of obesity and NASH. CONCLUSION: These results suggest that lipotoxic activation of TBK1 and subsequent p62 phosphorylation are critical steps in the NASH pathology of protein inclusion accumulation in hepatocytes. This mechanism can provide an explanation for how hypernutrition and obesity promote the development of severe liver pathologies, such as steatohepatitis and liver cancer, by facilitating the formation of p62 inclusions. (Hepatology 2018).
Authors: Stephen Caldwell; Yoshihiro Ikura; Daniela Dias; Kosuke Isomoto; Akito Yabu; Christopher Moskaluk; Patcharin Pramoonjago; Winsor Simmons; Harriet Scruggs; Nicholas Rosenbaum; Timothy Wilkinson; Patsy Toms; Curtis K Argo; Abdullah M S Al-Osaimi; Jan A Redick Journal: J Hepatol Date: 2010-06-25 Impact factor: 25.083
Authors: Shannon M Reilly; Maryam Ahmadian; Brian F Zamarron; Louise Chang; Maeran Uhm; BreAnne Poirier; Xiaoling Peng; Danielle M Krause; Evgenia Korytnaya; Adam Neidert; Christopher Liddle; Ruth T Yu; Carey N Lumeng; Elif A Oral; Michael Downes; Ronald M Evans; Alan R Saltiel Journal: Nat Commun Date: 2015-01-12 Impact factor: 14.919
Authors: Robert A Egnatchik; Alexandra K Leamy; Sarah A Sacco; Yi Ern Cheah; Masakazu Shiota; Jamey D Young Journal: J Biol Chem Date: 2018-12-18 Impact factor: 5.157
Authors: Karla K Frietze; Alyssa M Brown; Dividutta Das; Raymond G Franks; Jessie Lee Cunningham; Michael Hayward; Joseph T Nickels Journal: Autophagy Date: 2021-05-09 Impact factor: 16.016
Authors: David Schlütermann; Niklas Berleth; Jana Deitersen; Nora Wallot-Hieke; Olena Friesen; Wenxian Wu; Fabian Stuhldreier; Yadong Sun; Lena Berning; Annabelle Friedrich; María José Mendiburo; Christoph Peter; Constanze Wiek; Helmut Hanenberg; Anja Stefanski; Kai Stühler; Björn Stork Journal: Sci Rep Date: 2021-07-05 Impact factor: 4.379